Throne Biotechnologies Inc.
PrivateLast Round
Crowdfunding
Jul 14, 2022
Est. Valuation
$120.04M
Total Funding Raised
$475,006
Company Overview
Throne Biotechnologies Inc. is a biotechnology company that develops a disruptive stem cell technology, Stem Cell Educator therapy, to reverse autoimmune diseases like type 1 diabetes and alopecia areata.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Throne Biotechnologies Inc. Comparables
Compare Throne Biotechnologies Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NextCell Pharma AB | 74% | |
| Seraxis | 66% | |
| Sana Biotechnology | 64% |
Throne Biotechnologies Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Jul 14, 2022 | ||||
| Convertible Debt | Dec 31, 2021 |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 14, 2026
Monthly visitors increased 43% MoM.
- Apr 18, 2026
Monthly visitors increased 46% MoM, reaching 2.7K.
Throne Biotechnologies Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Throne Biotechnologies Inc.'s valuation, stock price, and market status.
Is Throne Biotechnologies Inc. a public or private company?
Throne Biotechnologies Inc. is a private company.
What is the current stock price of Throne Biotechnologies Inc.?
Throne Biotechnologies Inc. is a private company, so its shares have no public market price. Caplight tracks Throne Biotechnologies Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Throne Biotechnologies Inc. worth (valuation)?
Throne Biotechnologies Inc.'s valuation is estimated at $120.0M based on funding round data.
Can I buy Throne Biotechnologies Inc. stock?
Throne Biotechnologies Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Throne Biotechnologies Inc.'s last funding round?
Throne Biotechnologies Inc.'s most recent funding round was Crowdfunding on July 14, 2022.
Who are the main investors in Throne Biotechnologies Inc.?
Investor information for Throne Biotechnologies Inc. is not publicly disclosed.
Will Throne Biotechnologies Inc. IPO soon?
No public IPO plans have been announced for Throne Biotechnologies Inc..
How can I track Throne Biotechnologies Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Throne Biotechnologies Inc.'s shares on secondary markets.